Presentation TCT 2017 The Landscape of CV Device Innovation for Children: Regulatory View Presenter: Nicole Ibrahim, Satoshi Yasukochi, Sara Takahashi October 30, 2017
Presentation TCT 2017 FDA Perspectives: Diversity in Clinical Trials and its Impact of Device Evaluation Presenter: Wayne B. Batchelor, George A. Mensah, Christopher J Popma October 30, 2017
Presentation TCT 2017 The Landscape of CV Device Innovation for Children: Regulatory View Presenter: Nicole Ibrahim, Satoshi Yasukochi, Nicole Milligan October 30, 2017
Presentation TCT 2017 The Landscape of CV Device Innovation for Children: Industry View Presenter: Nicole Ibrahim, Satoshi Yasukochi, Lisa Becker October 30, 2017
Presentation TCT 2017 CMS Perspectives on Post-Approval Device Evaluation(Including NEST) and Reimbursement Presenter: Mitchell W. Krucoff, John C Laschinger, Daniel A Canos October 30, 2017
Presentation TCT 2017 The Landscape of CV Device Innovation for Children: Industry View Presenter: Nicole Ibrahim, Satoshi Yasukochi, Declan Dineen October 30, 2017
Presentation TCT 2017 Office, Home, or Ambulatory Blood Pressure: How to Measure Blood Pressure in Practice and Clinical Trials Presenter: Sidney C. Smith, Michael A. Weber, C. Venkata S. Ram October 30, 2017
Presentation TCT 2017 National Evaluation System for Health Technology (NEST): Objectives, Accomplishments and Future Directions Presenter: Mitchell W. Krucoff, John C Laschinger, Rachael L. Fleurence October 30, 2017
Presentation TCT 2017 Current CV Device Use and Unmet Needs in Children: US Academic View Presenter: Nicole Ibrahim, Satoshi Yasukochi, Frank F. Ing October 30, 2017
Presentation TCT 2017 Can Post-Approval Registries Inform Device Label Expansion? The TVT Case Example Presenter: Mitchell W. Krucoff, John C Laschinger, E. Murat Tuzcu October 30, 2017
Presentation TCT 2017 Current CV Device Use and Unmet Needs in Children: Japanese Academic View Presenter: Nicole Ibrahim, Satoshi Yasukochi, Hideshi Tomita October 30, 2017
Presentation TCT 2017 Recent Clinical Trials and Nonrandomized Studies That Will Change Your Daily Practice Presenter: Sidney C. Smith, Michael A. Weber, Vasilios Papademetriou October 30, 2017
Presentation TCT 2017 Introduction and Achievement of HBD-for-Children Presenter: Nicole Ibrahim, Satoshi Yasukochi, Yasuko Nakamura October 30, 2017
Presentation TCT 2017 Enhancing Pre-Approval Studies to Better Evaluate Real-World Use: Lessons Learned and Future Opportunities Presenter: Mitchell W. Krucoff, John C Laschinger October 30, 2017
Presentation TCT 2017 EFS in Japan & USA: Industry View Presenter: Mitchell W. Krucoff, Kiyohito Nakai, Robert Thatcher October 30, 2017
Presentation TCT 2017 EFS in Japan: PMDA View Presenter: Mitchell W. Krucoff, Kiyohito Nakai, Sara Takahashi October 30, 2017
Presentation TCT 2017 Do Japanese Patients & Doctors Want EFS: Academic View Presenter: Mitchell W. Krucoff, Kiyohito Nakai, Shigeru Saito October 30, 2017
Presentation TCT 2017 EFS FDA Guidance: History & Overview Presenter: Mitchell W. Krucoff, Kiyohito Nakai, Andrew Farb October 30, 2017
Presentation TCT 2017 Real World Evidence: Industry view Presenter: Daniel A Canos, Kazuhiro Sase, Larry L. Wood October 30, 2017
Presentation TCT 2017 Real World Evidence: Academic view Presenter: Daniel A Canos, Kazuhiro Sase, Mitchell W. Krucoff October 30, 2017